A commonly prescribed antibiotic used to treat sexually transmitted infections and other conditions is facing a shortage after President Trump promoted it as a potential coronavirus treatment. Demand ...
Pharmaceutical and biotechnology major Wockhardt will be launching Azithromycin tablets in the United States. Wockhardt Limited received approval from the United States Food & Drug Administration (US ...
Background Azithromycin mass drug administration (MDA) to ages 1–59 months can reduce childhood mortality; however, more ...
Wockhardt Ltd has announced plans for the immediate launch of Azithromycin tablets in the US markets for which it had earlier received approval from the United States Food and Drug Administration (US ...
Azithromycin is facing liquid formulation shortages. The Therapeutic Goods Administration expects the shortage to last until towards the end of the year. There are challenges with the pill versions ...
This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature will be posted on Medscape on a weekly basis. May 13, ...
To earn CME related to this news article, click here. This activity is part of an ongoing CME/CE initiative to provide information on labeling changes reported by the FDA. Activities of this nature ...
New research has suggested that a treatment of gentamicin with azithromycin was almost as effective as the currently used ceftriaxone for treating genital gonorrhea. Among growing concerns of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback